--- title: The Effects of Faculty/Staff Exercise Program nct_id: NCT03385447 overall_status: COMPLETED phase: NA sponsor: Kent State University study_type: INTERVENTIONAL primary_condition: Cardiovascular Risk Factor canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03385447.md" clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03385447" ct_last_update_post_date: 2017-12-28 last_seen_at: "2026-05-12T07:30:20.485Z" source: ClinicalTrials.gov (mirrored, no enrichment) --- # The Effects of Faculty/Staff Exercise Program **Official Title:** The Physiological and Cognitive Effects of Faculty/Staff Exercise Program in a University Setting **NCT ID:** [NCT03385447](https://clinicaltrials.gov/study/NCT03385447) ## Key Facts - **Status:** COMPLETED - **Phase:** NA - **Study Type:** INTERVENTIONAL - **Target Enrollment:** 50 - **Lead Sponsor:** Kent State University - **Conditions:** Cardiovascular Risk Factor, Sedentary Lifestyle, Physical Activity - **Start Date:** 2013-06-26 - **Completion Date:** 2013-10-11 - **CT.gov Last Update:** 2017-12-28 ## Brief Summary This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. ## Detailed Description This study focuses on analyzing the data collected from participants in the Faculty/Staff Exercise Program to determine the success and quantifying the results of the program. The investigators are interested in the effectiveness of this program on multiple levels, individual and group, as it is the first of its kind - an exercise program targeting the faculty and staff at a university. Participants were regular attendees in either a 6am or 12pm exercise program session. Data included both measures of physical health as well as cognitive health. Measures of physical health included the assessment of body fat using the skin-fold method of analysis (3-site). Cholesterol was measured via blood draw analysis. This was done at the Kent State University Exercise Physiology Laboratory by certified research staff. A 6 minute walk test was completed to measure aerobic capacity. Flexibility was assessed via the sit-and-reach test while anaerobic strength and endurance were assessed using sit-up and curl-up tests. Assessment of balance was done using a Biodex Balance System. Assessments of cognitive health included several questionnaires that asked questions related to sleep habits, stress levels, and mood. In addition, each participant was given a MOVband to track physical activity. The device was worn during waking hours for all days of participation.The data from the MOVband was auto-uploaded to a computer program for tracking so that no manual entry was necessary. ## Eligibility - **Minimum age:** 21 Years - **Maximum age:** 65 Years - **Sex:** ALL - **Healthy Volunteers:** Yes ``` Inclusion Criteria: * age 21-65 years * current faculty/staff member * no contraindications to exercise * sedentary prior to enrollment Exclusion Criteria: * age \<21 years, \>65 years * non faculty/staff member * contraindications to exercise * regular exercise participation prior to enrollment ``` ## Arms - **Physical Activity** (EXPERIMENTAL) — Participants were subjected to a 12-week exercise program targeting the federal physical activity guidelines. ## Interventions - **Physical Activity** (BEHAVIORAL) — Participants underwent 12-weeks of exercise prescription aimed at the federal guidelines (3 days/week). ## Primary Outcomes - **Height** _(time frame: Assessed once at baseline.)_ — Objectively measured height in meters using a standard clinical stadiometer. - **Weight** _(time frame: Change from baseline weight at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured weight in kilograms using a standard clinical scale. - **Systolic Blood Pressure** _(time frame: Change from baseline systolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured systolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. - **Diastolic Blood Pressure** _(time frame: Change from baseline diastolic blood pressure at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured diastolic blood pressure in millimeters of Mercury using a standard Mercury sphygmomanometer. - **High-Density Lipoprotein** _(time frame: Change from baseline high-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured high-density lipoprotein in milligrams per deciliter using a standard assay kit. - **Low-Density Lipoprotein** _(time frame: Change from baseline low-density lipoprotein at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured low-density lipoprotein in milligrams per deciliter using a standard assay kit. - **Total Serum Cholesteral** _(time frame: Change from baseline total serum cholesterol at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured total serum cholesterol in milligrams per deciliter using a standard assay kit. - **Impaired Fasting Glucose** _(time frame: Change from baseline impaired fasting glucose at 4-weeks, 8-weeks, and 12-weeks follow-up.)_ — Objectively measured impaired fasting glucose in milligrams per deciliter using a standard assay kit. ## Secondary Outcomes - **Accelerometer-Based Physical Activity** _(time frame: Change from baseline accelerometer-based physical activity 4-weeks, 8-weeks, and 12-weeks follow-up using 1-minute epochs.)_ ## Recent Field Changes (last 30 days) - `status.overallStatus` — added _(2026-05-12)_ - `status.primaryCompletionDate` — added _(2026-05-12)_ - `status.completionDate` — added _(2026-05-12)_ - `status.lastUpdatePostDate` — added _(2026-05-12)_ - `design.phases` — added _(2026-05-12)_ - `design.enrollmentCount` — added _(2026-05-12)_ - `eligibility.criteria` — added _(2026-05-12)_ - `eligibility.minAge` — added _(2026-05-12)_ - `eligibility.maxAge` — added _(2026-05-12)_ - `eligibility.sex` — added _(2026-05-12)_ - `outcomes.primary` — added _(2026-05-12)_ - `outcomes.secondary` — added _(2026-05-12)_ - `armsInterventions.arms` — added _(2026-05-12)_ - `armsInterventions.interventions` — added _(2026-05-12)_ - `sponsor.lead` — added _(2026-05-12)_ - `results.hasResults` — added _(2026-05-12)_ --- *Canonical: https://parkinsonspathways.com/agent/trials/NCT03385447.md* *Source data (authoritative): https://clinicaltrials.gov/study/NCT03385447* *This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*